Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Search for other papers by Jennifer Lo in
Google Scholar
PubMed
Search for other papers by Natasha Ascui in
Google Scholar
PubMed
Search for other papers by Matthew J Watt in
Google Scholar
PubMed
(TNF)α, interleukin (IL)-6, IL-1β and monocyte chemoattractant protein (MCP)-1 (for review, see Olefsky and Glass (37) ). It is important to note that this obesity-driven inflammatory state is characterised by small increases in blood cytokine levels
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Search for other papers by Hershel Raff in
Google Scholar
PubMed
Search for other papers by Hariprasad Trivedi in
Google Scholar
PubMed
's syndrome) (1, 2, 3, 4, 5, 6, 7) . It is now accepted that an increased late-night salivary cortisol (at the circadian nadir) has 90–95% sensitivity and specificity for the diagnosis of Cushing's syndrome (6, 7) . In patients with normal renal function
Search for other papers by Tingting Xia in
Google Scholar
PubMed
Search for other papers by Hongru Sun in
Google Scholar
PubMed
Search for other papers by Hao Huang in
Google Scholar
PubMed
Search for other papers by Haoran Bi in
Google Scholar
PubMed
Search for other papers by Rui Pu in
Google Scholar
PubMed
Search for other papers by Lei Zhang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Zhang in
Google Scholar
PubMed
Search for other papers by Ying Liu in
Google Scholar
PubMed
Search for other papers by Jing Xu in
Google Scholar
PubMed
Search for other papers by Justina Ucheojor Onwuka in
Google Scholar
PubMed
Search for other papers by Yupeng Liu in
Google Scholar
PubMed
Search for other papers by Binbin Cui in
Google Scholar
PubMed
Search for other papers by Yashuang Zhao in
Google Scholar
PubMed
Introduction Worldwide, colorectal cancer (CRC) remains among the top three prevalent tumors among women and men according to Global Cancer Statistics with an estimated 1.4 million new cases and 693,900 deaths occurring in 2012 ( 1
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Laia Faseh in
Google Scholar
PubMed
Department of Medicine, Karlstad Hospital, Karlstad, Sweden
Search for other papers by Christos Himonakos in
Google Scholar
PubMed
Search for other papers by Tomasz Pielak in
Google Scholar
PubMed
Search for other papers by Jesper Eugen-Olsen in
Google Scholar
PubMed
markers ( 1 , 2 , 3 , 4 , 5 , 6 ). In accordance, previous epidemiological studies found an increased mortality in GHD, particularly for CVD ( 7 , 8 , 9 ). However, this was less clear from more recent studies ( 10 , 11 ). Numerous studies have
Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed
Search for other papers by Anna De Tullio in
Google Scholar
PubMed
Search for other papers by Olga Disoteo in
Google Scholar
PubMed
Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed
Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed
Search for other papers by Carlo Sabbà in
Google Scholar
PubMed
Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed
in the pro-inflammatory background (interleukin 6 and tumor necrosis factor alpha), insulin resistance, hyperglycemia, dyslipidemia, and altered signaling of thyroid-stimulating hormone, insulin growth factor 1, leptin, adiponectin, and androgens
Search for other papers by R A M Quax in
Google Scholar
PubMed
Search for other papers by J A M van Laar in
Google Scholar
PubMed
Search for other papers by R van Heerebeek in
Google Scholar
PubMed
Search for other papers by K Greiner in
Google Scholar
PubMed
Search for other papers by E Ben-Chetrit in
Google Scholar
PubMed
Search for other papers by M Stanford in
Google Scholar
PubMed
Search for other papers by G R Wallace in
Google Scholar
PubMed
Search for other papers by F Fortune in
Google Scholar
PubMed
Search for other papers by M Ghabra in
Google Scholar
PubMed
Search for other papers by M Soylu in
Google Scholar
PubMed
Search for other papers by J M W Hazes in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by J H Kappen in
Google Scholar
PubMed
Search for other papers by P M van Hagen in
Google Scholar
PubMed
Search for other papers by J W Koper in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
of GRs per cell was about three fold higher in monocytes as compared with lymphocytes (data not shown). Figure 1 Cellular GC sensitivity in Behçet's disease and healthy controls. EC 50 (nM DEX) values of interleukin 2 (A) and glucocorticoid (GC
Search for other papers by K L Gatford in
Google Scholar
PubMed
Search for other papers by G K Heinemann in
Google Scholar
PubMed
Search for other papers by S D Thompson in
Google Scholar
PubMed
Search for other papers by J V Zhang in
Google Scholar
PubMed
Search for other papers by S Buckberry in
Google Scholar
PubMed
Search for other papers by J A Owens in
Google Scholar
PubMed
Search for other papers by G A Dekker in
Google Scholar
PubMed
Search for other papers by C T Roberts in
Google Scholar
PubMed
Search for other papers by on behalf of the SCOPE Consortium in
Google Scholar
PubMed
Introduction The insulin-like growth factors (IGFs), IGF1 and IGF2, are important regulators of placental and foetal development, as well as postnatal growth and metabolism. In humans, circulating IGF1 peaks in adolescence and then falls with age
Search for other papers by Martin Wiegand in
Google Scholar
PubMed
Search for other papers by David J Halsall in
Google Scholar
PubMed
Search for other papers by Sarah L Cowan in
Google Scholar
PubMed
Search for other papers by Kevin Taylor in
Google Scholar
PubMed
Search for other papers by Robert J B Goudie in
Google Scholar
PubMed
Search for other papers by Jacobus Preller in
Google Scholar
PubMed
Wellcome–MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
supplementary materials given at the end of this article), although these patients had lower interleukin-6 (median 8.1 vs 11.9); were less likely to be admitted to ICU (11.2% vs 18.9%); and were more likely to have diabetes (32.8% vs 20.7%) or other endocrine
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, University Regional Hospital of Patras, Rio, Greece
Mount Auburn Hospital, Harvard Medical School Teaching Hospital, Cambridge, Massachusetts, USA
Search for other papers by M I Stamou in
Google Scholar
PubMed
Search for other papers by P Varnavas in
Google Scholar
PubMed
Search for other papers by L Plummer in
Google Scholar
PubMed
Search for other papers by V Koika in
Google Scholar
PubMed
Search for other papers by N A Georgopoulos in
Google Scholar
PubMed
– fibroblast growth factor 17, IL17RD – interleukin 17 receptor D, PROK2 – prokineticin 2, PROKR2 – prokineticin receptor 2, HS6ST1 – heparin sulfate 6 O sulfutransferase, CHD7 – chromodomain helicase DNA-binding protein 7, WDR11 – WD repeat
Search for other papers by Jaafar Jaafar in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Heba Alwan in
Google Scholar
PubMed
Search for other papers by Jacques Philippe in
Google Scholar
PubMed
-1 antibodies (PD-1 Ab) and its ligand programmed cell death ligand 1 antibodies (PD-L1 Ab), has undoubtedly been proven in the management of several advanced cancers, namely melanoma, non-small cell lung cancers (NSCLC), urothelial cancers, head and